A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy

DOI Web Site 1 Citations

Anna Asklid

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;
Sandra Eketorp Sylvan

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;
Agnes Mattsson

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;
Maria Winqvist

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;
Hemming Johansson

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;
Anders Österborg

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;
Lotta Hansson

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;